Angiodynamic OverviewAngiodynamic EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ANGO.
Quarterly EBIT
-$10.93M
↓ 1877.24% YoY
As of May 31, 2026
Annual EBIT (TTM)
-$26.19M
↓ 8.21% YoY
Trailing 12 months ending May 31, 2026
Angiodynamic OverviewEBIT (Earnings Before Interest and Taxes) analysis for ANGO.
As of May 31, 2026
Trailing 12 months ending May 31, 2026